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a b s t r a c t
INTRODUCTION: Ulcerative colitis is an idiopathic inﬂammatory bowel condition whose peak incidence
coincides with fertility in female patients. In pregnancy, acute fulminant colitis is rare, and, when it
becomes refractory to maximum medical therapy, emergency colectomy is mandated. Over the past
quarter century, there have been few reports of this rare event in the literature.
PRESENTATIONOFCASE:Wereport a26yearoldprimigravida femalewhopresentedwith toxicmegacolon
during the third trimester of pregnancy, unresponsive to medical therapy. She subsequently under-
went an urgent low transverse caesarean section with a total colectomy. Both mother and child made a
satisfactory recovery post operatively.
DISCUSSION: Although the fetus is at higher risk than the mother in such a circumstance, morbidity and
mortality rates are still noticeably high for both, and therefore, prompt diagnosis is key.
CONCLUSION: It is imperative that female patients planning to conceive with a known diagnosis of ulcer-
ative colitis liaise with their obstetricians and gastroenterologists early to optimise medical treatment to
prevent the development of a toxic megacolon and that conception is planned during a state of remis-
sion. Should surgical intervention become required, this can be performed with favourable outcomes for
mother and child, as demonstrated in this report.
© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Ulcerative colitis (UC) was ﬁrst described by the British physi-
cian Sir Samuels Wilks in 1859 [1]. It is an idiopathic inﬂammatory
bowel condition, depicted as a chronic, relapsing disease whose
intestinalmanifestationsare restricted to thecolon [1,2], althougha
subset of patients may also develop ileal inﬂammation or so-called
‘backwash ileitis’ [2,3]. It has been estimated that between 30 and
50% of female patients with UC will have an exacerbation during
pregnancy or in the early postpartum period [4–7]. Patients with
active disease at the time of conception may have an increased
risk of spontaneous abortion. Rates of preterm delivery, low birth
weight (<2500g), and congenital anomalies are also increased [8].
A rare but potentially fatal complication of UC is toxic megacolon.
This condition is characterisedpathologically by severe, transmural
inﬂammation with inﬁltration of the colonic wall by neutrophils,
lymphocytes, histiocytes and plasma cells [9]. The most signiﬁcant
risk of toxic megacolon is perforation into the surrounding perit-
oneal cavity which holds a considerable mortality rate due to the
sequalae of sepsis [10–12]. The development of toxic megacolon
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during pregnancy is an unusual occurrence. Only seven authors
with a combined eleven cases have been described in the litera-
ture (Table 1) [11–17]. Here, we illustrate a case report of a 26 year
old female that developed toxic megacolon at 31 weeks gestation.
2. Case report
A 26 year old primigravida female with an eight year history
of ulcerative colitis presented to the emergency department with
abdominalpain, fever, bloodydiarrhoea, andgeneralisedweakness.
At this initial presentation, the patient was at 26 weeks gesta-
tion and had poorly controlled colitis requiring tri-modal therapy
with mesalazine, 6-mercaptopurine and prednisolone. The patient
was stabilised initially with conservative management including
analgesia, intravenous ﬂuids and intravenous steroids and was
subsequently discharged. She was then readmitted at 31 weeks
gestation with systemic signs of sepsis, including tachycardia,
hypotension and a pyrexia of 38.3 ◦C. Physical examination demon-
strated a distended abdomen consistent with pregnancy, which
was exquisitely tender on palpation and percussion with positive
rebound tenderness indicative of peritonitis. Plain ﬁlm abdom-
inal X-ray demonstrated severe colonic distension without free
air (Fig. 1). The patient underwent an emergent caesarean section
via an infra-umbilical midline incision. The fetus was successfully
http://dx.doi.org/10.1016/j.ijscr.2015.04.033
2210-2612/© 2015 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Table 1
Summary of reported cases of toxic megacolon in pregnancy.
Authors Year n Maternal gestation (weeks)a Maternal mortality (%) Fetal mortality (%) Pooled fetal and maternal mortality (%)
Marshak et al. [15] 1960 1 24 0 100 50
Peskin and Davis [16] 1960 1 24 0 100 50
Holzbach [17] 1969 2 22,30 50 100 75
Becker [12] 1972 1 23 0 0 0
Cooksey et al. [13] 1985 1 24 0 0 0
Anderson et al. [14] 1987 3 33,34,37 0 33 17
Ooi et al. [11] 1985 2 10,16 0 0 0
Total – 11 – – – –
a Represents the gestational period at which the diagnosis of toxic megacolon was established.
Fig. 1. Preoperative plain ﬁlm abdominal radiograph of a 26 year old lady with
suspected toxic colitis. The single frontal supine view demonstrates a diffusely dis-
tended transverse colon with displacement by the gravid uterus.
delivered with apgar (appearance, pulse, grimace, activity, respi-
ration) scores of 9 at one minute and 9 at ﬁve minutes; weight
1.474kg and height 36.2 cm. Immediately after delivery, the mid-
line incisionwas extended approximately 2 cmcephalad and a total
abdominal colectomy with end ileostomy was performed. Total
operative time for the combined procedures was 96min and esti-
mated blood losswas 250ml. The patientwas discharged nine days
postoperatively in stable condition; while the neonate was sta-
bilised in the intensive care unit, where, ventilator support was
initially required. He was weaned off of the ventilator, transitioned
to a neonatal progressive care unit and eventually dischargedhome
two weeks after birth. Pathologic examination of the surgical spec-
imen conﬁrmed the diagnosis of toxic megacolon with transmural
inﬂammation and erosion of the bowel wall in regions (Fig. 2). Four
weeks post-operatively, the patient underwent completion proc-
tectomy and creation of an ileal reservoir with construction of an
ileoanal anastomosis and diverting ileostomy. The reason for accel-
erating the procedure was based on patient choice and the fact that
she had recovered very well from her emergency colectomy. Oper-
ative time was 177min and estimated blood loss was 200ml. The
loop ileostomy was reversed three months later (Fig. 3).
Two months following the loop ileostomy reversal the patient
was seen in clinic reporting 2–3 bowel movements a day,
constitutionally well with optimal healing of her surgical wounds.
The effect of reduced fertility due to the ileal pouch-anal anas-
tomosis (IPAA) formation in the future was explained during the
consultation. Theneonatemeasuredbetween40and50th centile in
all his growth assessments andhe alsomade a satisfactory recovery
from the procedure.
3. Discussion
Although ulcerative colitis has a peak incidence which coin-
cides with females of childbearing age, it does not affect fertility in
women unless they have undergone curative treatment in the form
of a proctocolectomy plus IPAA [18]. Several meta-analyses have
found that IPAA conferred a two to three fold increased risk of infer-
tility compared with medical management [19,20] The most likely
mechanisms for impaired fertility following surgery are higher
rates of hydrosalpinx, destruction of ﬁmbria and tubal obstruction
due to adhesions and scarring [21].
Studies have shown that disease status at the time of conception
plays a vital role in predicting disease activity during pregnancy
and also on the outcome of the pregnancy [22]. When conception
occurs during a period of remission in inﬂammatory bowel dis-
ease then the risk of relapse during pregnancy is one-third and
these patients are more likely to have quiescent disease activity
during pregnancy [23]. This is the same risk of relapse in non-
pregnant patients with Crohn’s disease. Conversely, women with
UC or Crohn’s have a twofold risk of developing exacerbations dur-
ing pregnancy if during conception they had active disease [24,25].
The underlying cause for the increased risk is not clearly under-
stood.
In addition, active inﬂammatory bowel disease at the time of
conception and during pregnancy has been shown to be associated
with a high risk pre-term birth, low birth weight and small for ges-
tational age birth comparedwithwomenwith IBDwhose disease is
in remission during conception and during the course of the preg-
nancy [26–28]. Other predictors of adverse pregnancy outcomes
include family history of IBD, disease localisation and IBD surgery
[26–28].
Females that have an exacerbation of ulcerative colitis during
their pregnancy (most likely ﬁrst trimester [13]) or early post-
partum period, are initially treated medically. Ulcerative colitis
during pregnancy that is refractory to medical therapy can lead
to the development of toxic megacolon. Over the past quarter of a
century, there have been no reports of this rare event. This is per-
haps because of improvements in the medications used to treat
inﬂammatory bowel disease, including new classes of medicines
– most notably recombinant monoclonal antibodies which target
TNF-alpha (e.g. Inﬂiximab). Previous literature demonstrates that
different surgical options have been applied to thepregnant patient
with a toxic megacolon [11–17]. Despite these variances is surgical
approach, the objective is twofold: (a) save themother by removing
the diseased organ and (b) deliver the fetus, if at a viable gestation
age. It is clear that fetalmortality is higher thanmaternalmortality,
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Fig. 2. Macroscopic aspect of the colonic mucosa after total colectomy. A disruption on the wall of the ascending colon was noted as well as profuse haemorrhage and areas
of intramural inﬂammation, with sparing of the ileocaecal valve and ileum.
Fig. 3. Infraumbilical laparotomy and closure of ileostomy scars two months after
ileostomy reversal.
particularly when toxic megacolon occurs in the second trimester
(Table 1) but morbidity and mortality rates are still noticeably high
for both [14].
4. Conclusion
Ulcerative colitis refractory to medical therapy during preg-
nancy is rare however mandatory surgical intervention carries
signiﬁcant morbidity and mortality for both mother and fetus.
Therefore, it is imperative that female patients planning to con-
ceivewith a knowndiagnosis of ulcerative colitis have anoptimised
medical regimen to prevent exacerbations and the development
of toxic megacolon. Should surgical intervention become required,
this can be safely performed with favourable outcomes for mother
and child, as demonstrated in this report.
Conﬂict of interest






Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy
of the written consent is available for review by the Editor-in-Chief
of this journal on request.
Authors contribution
Ayyaz Quddus, Henry Schoonyoung and Beatriz Martin Perez –
wrote the article. Matthew Albert and Sam Atallah alongside Henry
Schoonyoung – participated in the diagnosis and treatment of the
present case. All authors approved the ﬁnal manuscript.
Guarantor
Dr. Sam Atallah and Ayyaz Quddus.
References
[1] D.C. Baumgart, S.R. Carding, Inﬂammatory bowel disease: cause and
immunobiology, Lancet 369 (2007) 1627–1640.
[2] D.C. Baumgart, W.J. Sandborn, Inﬂammatory bowel disease: clinical aspects
and established and evolving therapies, Lancet 369 (2007) 1641–1657.
[3] A.C. Ford, Ulcerative colitis: clinical review, BMJ 346 (2013) f432.
[4] C.P. Willoughby, S.C. Truelove, Ulcerative colitis and pregnancy, Gut 6 (1980)
469–474.
[5] B.I. Korelitz, Inﬂammatory bowel disease and pregnancy, Gastroenterol. Clin.
North Am. 1 (1998) 213–224.
[6] K.O. Olsen, S. Juul, I. Berndtsson, T. Oresland, S. Laurberg, Ulcerative colitis:
female fecundity before diagnosis, during disease, and after surgery
compared with a population sample, Gastroenterology 122 (2002) 15–19.
[7] E.J. Dozois, B.G. Wolff, W.J. Tremaine, W.J. Watson, E.R. Drelichman, P.W.
Carne, et al., Maternal and fetal outcome after colectomy for fulminant
ulcerative colitis during pregnancy: case series and literature review, Dis.
Colon Rectum 49 (2006) 64–73.
[8] J. Cornish, E. Tan, J. Teare, T.G. Teoh, R. Rai, S.K. Clark, et al., A meta-analysis on
the inﬂuence of inﬂammatory bowel disease on pregnancy, Gut 56 (2007)
830–837.
[9] R.A. Sheik, Y. Shagufta, T. Prindiville, Toxic megacolon a review, JK Practioner
10 (2003) 176–178.
[10] S.G. Sheth, J.T. Lamont, Toxic megacolon, Lancet 351 (1998) 509–513.
CASE REPORT – OPEN ACCESS
86 A. Quddus et al. / International Journal of Surgery Case Reports 11 (2015) 83–86
[11] B.S. Ooi, F.H. Remzi, V.W. Fazio, Turnbull-Blowhole colostomy for toxic
ulcerative colitis in pregnancy: report of two cases, Dis. Colon Rectum 46
(2003) 111–115.
[12] I.M. Becker, Pregnancy and toxic dilatation of the colon, Am. J. Digest. Dis. 17
(1972) 79–84.
[13] G. Cooksey, A. Gunn, W.C. Wotherspoon, Surgery for acute ulcerative colitis
and toxic megacolon during pregnancy, Br. J. Surg. 72 (1985) 547.
[14] J.B. Anderson, G.M. Turner, R.C. Williamson, Fulminant ulcerative colitis in
late pregnancy and the puerperium, J. Soc. Med. 80 (1987) 492–494.
[15] R.H. Marshak, B.J. Korelitz, S.H. Klein, Toxic dilatation of the colon in the
course of ulcerative colitis, Gastroenterology 38 (1960) 165–180.
[16] G.W. Peskin, A.V.O. Davis, Acute fulminating ulcerative colitis with colonic
distension, Surg. Gynecol. Obstet. 110 (1960) 269–276.
[17] R.T. Holzbach, Toxic megacolon in pregnancy, Am. J. Digest. Dis. 14 (1969)
908–910.
[18] E.M. Alstead, Inﬂammatory bowel disease in pregnancy, Postgrad. Med. J. 78
(2002) 23–26.
[19] S.G. Rajaratnam, T.W. Eglinton, P. Hider, N.S. Fearnhead, Impact of ileal
pouch-anal anastomosis on female fertility: meta-analysis and systematic
review, Int. J. Colorectal Dis. 26 (2011) 1365–1374.
[20] A. Waljee, J. Waljee, A.M. Morris, P.D. Higgins, Threefold increased risk of
infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in
ulcerative colitis, Gut 55 (2006) 1575–1580.
[21] T. Oresland, S. Palmblad, M. Ellström, I. Berndtsson, N. Crona, L. Hultén,
Gynaecological and sexual function related to anatomical changes in the
female pelvis after restorative proctocolectomy, Int. J. Colorectal Dis. 9 (1994)
77–81.
[22] A.A. Siddiqui, A. Mahboob, M. Ansari, I. Alam, B. Bashir, S. Ahmed, Effects of
pregnancy on disease activity in Ulcerative Colitis, J. Postgrad. Med. Inst. 25
(2011) 314–317.
[23] C.J. Van der Woude, S. Ardizzone, M.B. Bengtson, G. Fiorino, et al., The second
European evidenced-based consensus on reproduction and pregnancy in
inﬂammatory bowel disease, J. Crohns Colitis (2014) 107–124.
[24] G. Oron, Y. Yogev, S. Shkolnik, M. Hod, et al., Inﬂammatory bowel disease: risk
factors for adverse pregnancy outcome and the impact of maternal weight
gain, J. Matern. Fetal Neonatal. Med. 25 (2012) 2256–2260.
[25] A. Abhyankar, M. Ham, A.C. Moss, Meta-analysis the impact of disease activity
at conception on disease activity during pregnancy in patients with
inﬂammatory bowel disease, Aliment. Pharmacol. Ther. 38 (2013) 460–466.
[26] H.-C. Lin, C.-C.J. Chiu, S.-F. Chen, H.-Y. Lou, W.-T. Chiu, Y.-H. Chen, Ulcerative
colitis and pregnancy outcomes in an Asian population, Am. J. Gastroenterol.
105 (2010) 387–394.
[27] K. Hakimian, S.S. Kane, D.A. Corley, Pregnancy outcomes in women with
inﬂammatory bowel disease: a large community-based study from Northern
California, Gastroenterology 133 (2007) 1106–1112.
[28] G. Oron, Y. Yogev, S. Shkolnik, et al., Inﬂammatory bowel disease: risk factors
for adverse pregnancy outcome and the impact of maternal weight gain, J.
Matern. Fetal Neonatal. Med. 25 (2012) 2256–2260.
Open Access
This article is published Open Access at sciencedirect.com. It is distributed under the IJSCR Supplemental terms and conditions, which
permits unrestricted non commercial use, distribution, and reproduction in any medium, provided the original authors and source are
credited.
